Literature DB >> 10823578

The adenosine receptor agonist, APNEA, increases calcium influx into rat cortical synaptosomes through N-type channels associated with A2a receptors.

S N Li1, P T Wong.   

Abstract

N6-2-(4-aminophenyl)ethyladenosine (APNEA) is a nonselective adenosine receptor agonist known to have a high affinity for the adenosine A1 and A3 receptors. It was found to be able to dose-dependently increase the sustained (4 min) Ca2+ influx into rat cortical synaptosomes while 2-chloro-N6-(3-iodobenzyl)-adenosine-5-N-methyluronamide (Cl-IB-MECA), a selective A3 agonist has no effect. However, this effect of APNEA was not affected by the presence of 8-cyclopentyl-1,3-dimethylxanthine (CPT), a selective A1 antagonist; but instead completely abolished by 8-(3-chlorostyryl)caffeine (CSC), a selective A2a antagonist, or omega-conotoxin GVIA. These results show that in the rat cortex, presynaptic A2a receptors can mediate neurotransmitter release by increasing Ca2+ influx through the N-type calcium channels. A1 and A3 receptors appear not to be involved.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10823578     DOI: 10.1023/a:1007503907823

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  23 in total

Review 1.  Receptors for purines and pyrimidines.

Authors:  V Ralevic; G Burnstock
Journal:  Pharmacol Rev       Date:  1998-09       Impact factor: 25.468

2.  Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium.

Authors:  Y Kohno; X Ji; S D Mawhorter; M Koshiba; K A Jacobson
Journal:  Blood       Date:  1996-11-01       Impact factor: 22.113

Review 3.  Cloned adenosine A3 receptors: pharmacological properties, species differences and receptor functions.

Authors:  J Linden
Journal:  Trends Pharmacol Sci       Date:  1994-08       Impact factor: 14.819

4.  Preferential release of ATP and its extracellular catabolism as a source of adenosine upon high- but not low-frequency stimulation of rat hippocampal slices.

Authors:  R A Cunha; E S Vizi; J A Ribeiro; A M Sebastião
Journal:  J Neurochem       Date:  1996-11       Impact factor: 5.372

5.  Evidence that the presynaptic A2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase.

Authors:  P Correia-de-Sá; J A Ribeiro
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

6.  Excitatory and inhibitory effects of A1 and A2A adenosine receptor activation on the electrically evoked [3H]acetylcholine release from different areas of the rat hippocampus.

Authors:  R A Cunha; E Milusheva; E S Vizi; J A Ribeiro; A M Sebastião
Journal:  J Neurochem       Date:  1994-07       Impact factor: 5.372

7.  Molecular cloning and characterization of an adenosine receptor: the A3 adenosine receptor.

Authors:  Q Y Zhou; C Li; M E Olah; R A Johnson; G L Stiles; O Civelli
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

8.  Differential activation of adenosine receptors decreases N-type but potentiates P-type Ca2+ current in hippocampal CA3 neurons.

Authors:  D J Mogul; M E Adams; A P Fox
Journal:  Neuron       Date:  1993-02       Impact factor: 17.173

Review 9.  Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential.

Authors:  K A Jacobson; P J van Galen; M Williams
Journal:  J Med Chem       Date:  1992-02-07       Impact factor: 7.446

10.  2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors.

Authors:  H O Kim; X D Ji; S M Siddiqi; M E Olah; G L Stiles; K A Jacobson
Journal:  J Med Chem       Date:  1994-10-14       Impact factor: 7.446

View more
  3 in total

1.  A Novel Method for Screening Adenosine Receptor Specific Agonists for Use in Adenosine Drug Development.

Authors:  Karlie R Jones; Uimook Choi; Ji-Liang Gao; Robert D Thompson; Larry E Rodman; Harry L Malech; Elizabeth M Kang
Journal:  Sci Rep       Date:  2017-03-20       Impact factor: 4.379

2.  Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand.

Authors:  María Isabel Bahamonde; Jaume Taura; Silvia Paoletta; Andrei A Gakh; Saibal Chakraborty; Jordi Hernando; Víctor Fernández-Dueñas; Kenneth A Jacobson; Pau Gorostiza; Francisco Ciruela
Journal:  Bioconjug Chem       Date:  2014-10-02       Impact factor: 4.774

Review 3.  Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

Authors:  Ágatha Oliveira-Giacomelli; Yahaira Naaldijk; Laura Sardá-Arroyo; Maria C B Gonçalves; Juliana Corrêa-Velloso; Micheli M Pillat; Héllio D N de Souza; Henning Ulrich
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.